Sugi Predict

Sugi Predict / Compounds / SCHEMBL29626845

SCHEMBL29626845

SCHEMBL29626845

CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.58
▸ CRHR1 P34998 1/20 0.58
▸ CRHR2 Q13324 1/20 0.58
▸ CALCR P30988 3/20 0.57
▸ NPY2R P49146 8/20 0.55
▸ NPY4R P50391 8/20 0.55
▸ NPY5R Q15761 8/20 0.55
▸ NPY1R P25929 6/20 0.55
▸ AGTR2 P50052 3/20 0.53
▸ AGTR1 P30556 2/20 0.53
▸ CXCL8 P10145 2/20 0.53
▸ TFPI P10646 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30363005 1.00 BACE1 (0.58) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL30761771 1.00 BACE1 (0.58) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL30362923 1.00 BACE1 (0.58) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL29693043 1.00 BACE1 (0.58) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL30362943 1.00 BACE1 (0.58) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL30363072 1.00 BACE1 (0.58) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL30362994 0.99 BACE1 (0.58) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL30363074 0.99 BACE1 (0.58) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL29501059 0.99 BACE1 (0.59) BACE1CRHR1CRHR2CALCRNPY2R
SCHEMBL30362874 0.99 CALCR (0.58) BACE1CRHR1CRHR2CALCRNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4740959-A2 THERAPEUTIC USE OF LEVOROTATORY -LACTAMS IN HEMATOPOIESIS, IMMUNO-ONCOLOGY THERAPY, AND REGULATION OF LIPOPROTEIN AND APOLIPOPROTEIN LEVELS Alpha-1 Biologics LLC (US) 2026-05-13 — — EP disclosed
EP-3570831-B1 THERAPEUTIC USE OF BETA-LACTAMS IN HEMATOPOIESIS, IMMUNO-ONCOLOGY THERAPY, AND REGULATION OF LIPOPROTEIN AND APOLIPOPROTEIN LEVELS ALPHA 1 BIOLOGICS LLC (US) 2026-03-25 — — EP disclosed
US-12097190-B2 Therapeutic use of levorotatory β-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels ALPHA-1 BIOLOGICS, LLC (US) 2024-09-24 — — US disclosed
EP-3412681-B1 PROTRANSDUCIN B AN ENHANCER OF GENE TRANSFER PHARIS BIOTEC GMBH (DE) 2024-04-17 — — EP disclosed
EP-4224163-A1 DIAGNOSIS OF SEPSIS AND SYSTEMIC INFLAMMATORY RESPONSE SYNDROME BY QUANTITATIVE LC/MS METHOD Universitätsklinikum Jena (DE) 2023-08-09 — — EP disclosed
US-11680086-B2 Lipopeptide for potently inhibiting HIV, derivative thereof, pharmaceutical composition thereof and use thereof Shanxi Kangbao Biological Product Co., Ltd. (CN) 2023-06-20 — — US disclosed
CN-115960215-A anti-HIV antibody 北京昭衍生物技术有限公司 2023-04-14 — — CN disclosed
CN-115716872-A anti-HIV antibody, preparation method and application thereof 北京昭衍生物技术有限公司 2023-02-28 — — CN disclosed
CN-114907490-B Potent bifunctional HIV entry inhibitor and application thereof 中国医学科学院病原生物学研究所 2022-12-09 — — CN disclosed
CN-111404763-B Core network performance test method, device and system 中国移动通信有限公司研究院 2022-11-08 — — CN disclosed
US-20220273626-A1 THERAPEUTIC USE OF LEVOROTATORY BETA-LACTAMS IN HEMATOPOIESIS, IMMUNO-ONCOLOGY THERAPY, AND REGULATION OF LIPOPROTEIN AND APOLIPOPROTEIN LEVELS ALPHA-1 BIOLOGICS, LLC 2022-09-01 — — US disclosed
CN-114907490-A Potent bifunctional HIV entry inhibitor and application thereof 中国医学科学院病原生物学研究所 2022-08-16 — — CN disclosed
CN-111643656-B Broad-spectrum coronavirus membrane fusion inhibitor and application thereof in resisting AIDS virus 悦康药业集团股份有限公司 2022-07-19 — — CN disclosed
EP-3538543-B1 PROTRANSDUZIN-S - AN ENHANCER OF GENE TRANSFER PHARIS BIOTEC GMBH (DE) 2022-06-08 — — EP disclosed
CN-111944025-B HIV (human immunodeficiency Virus) membrane fusion inhibitor lipopeptide and pharmaceutical application thereof 中国医学科学院病原生物学研究所 2022-06-07 — — CN disclosed
US-11324730-B2 Therapeutic use of levorotatory β-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels ALPHA-1 BIOLOGICS, LLC (US) 2022-05-10 — — US disclosed
Send feedback